About Mendel Bio
Mendel Bio is a Healthcare company based in Hayward (United States) founded in 1997, and was acquired by Koch Agronomic Services in December 2014. Transcription factor technology is developed for crop trait manipulation. It operates in the Healthcare and Agriculture sectors. Mendel Bio has raised $8.39 million across 1 funding round from investors including Koch Agronomic Services. The company has 5 employees. Mendel Bio offers products and services including Slot Games, Togel, Casino Games, Arcade Games, and Bola Games. Its focus areas include Life Sciences, Genomics, Applied Genomics and Synthetic Biology. Its competitors include Amyris, Benson Hill and Pivot Bio; 3 of its 3 listed competitors have raised funding.
Company details
Mendel Biotechnology was founded in 1997 in Hayward, United States, within the agricultural biotechnology sector. A platform based on transcription factors is developed to manipulate crop traits for desired outcomes. The technology has been patented and licensed to genetically engineered seed producers, including Monsanto and Bayer CropScience. Acquisition by Koch Agronomic Services occurred in December 2014, after which operations continued as an in-house research unit focused on transcription factor applications.
- Headquarters Hayward, United States
- Employees 5
- Stage Acquired
- SectorsHealthcareAgriculture
- Website mendelbio.com
- Social LinkedIn
- Acquired by Koch Agronomic Services (Dec 2014)
- Total Equity Funding$8.39M (USD)
in 1 rounds
- Latest Funding Round$8.39M (USD), Series A
Sep 2011
- Investors
- Employee Count5
- Acquired byKoch Agronomic Services
(Dec 2014)
Products & Services of Mendel Bio
Mendel Bio offers a comprehensive portfolio of products and services, including Slot Games, Togel, Casino Games, Arcade Games, and Bola Games.
Platform for playing slot machines with high RTP and jackpots.
Online system for lottery betting and results.
Digital casino offerings for various betting activities.
Interactive arcade-style games for user engagement.
Platform for sports-related gambling and wagering.
Funding Insights of Mendel Bio
Mendel Bio has successfully raised a total of $8.39M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.39 million completed in September 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.39M
- Total Rounds 1
- Last Round Series A — $8.39M
- First Round $8.39M
(Sep 2011)
All 1 funding rounds of Mendel Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2011 | $8.39M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Mendel Bio
Mendel Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Koch Agronomic Services.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers crop nutrient management and seed enhancement products for growers. | 2010 | kochagronomicservices.com | Wichita, United States |
Investor details for Mendel Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Mendel Bio
3 dated milestones of Mendel Bio across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Mendel Bio is founded.
- Funding First funding round of $8.4M.
- Exit Acquired by Koch Agronomic Services.
Competitors of Mendel Bio
Mendel Bio has 3 listed competitors in our database, 3 of them funded. They include Amyris, Benson Hill and Pivot Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amyris.com | 2003 | Emeryville, United States | $487.2M | 747 | Developer of renewable products for industrial solutions | |
| bensonhill.com | 2012 | St. Louis, United States | $406.99M | 151 | Provider of plant-based food ingredients | |
| pivotbio.com | 2010 | Berkeley, United States | $618.08M | 256 | Nitrogen-fixing microbes for corn crop nutrition are developed and applied. |
Detailed competitors of Mendel Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Mendel Bio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mendel Bio
Mendel Bio was founded in 1997 and raised its 1st funding round 14 years after it was founded.
Mendel Bio is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Mendel Bio is a funded company, having raised a total of $8.39M across 1 funding round to date. The company's 1st funding round was a Series A of $8.39M, raised on Sep 2011.
Mendel Bio has 5 employees.
Mendel Biotechnology was founded in 1997 in Hayward, United States, within the agricultural biotechnology sector. A platform based on transcription factors is developed to manipulate crop traits for desired outcomes. The technology has been patented and licensed to genetically engineered seed producers, including Monsanto and Bayer CropScience. Acquisition by Koch Agronomic Services occurred in December 2014, after which operations continued as an in-house research unit focused on transcription factor applications.
Mendel Bio's top competitors include Benson Hill, Amyris and Pivot Bio.
Mendel Bio offers Slot Games, Togel, Casino Games, Arcade Games, and Bola Games.
Mendel Bio has 1 investor. Key investors include Koch Agronomic Services.
Yes. Mendel Bio was acquired by Koch Agronomic Services in December 2014.